argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 775.60
+12.60 (1.65%)
Jun 11, 2026, 5:35 PM CET
argenx SE Employees
argenx SE had 1,863 employees as of December 31, 2025. The number of employees increased by 264 or 16.51% compared to the previous year.
Employees
1,863
Change (1Y)
264
Growth (1Y)
16.51%
Revenue / Employee
€2,207,806
Profits / Employee
€693,205
Market Cap
47.45B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,863 | 264 | 16.51% |
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,765 |
| Onward Medical | 137 |
| European Medical Solutions | 127 |
| Hyloris Pharmaceuticals | 55 |
| Oxurion NV | 26 |
| BioSenic | 7 |
| Celyad Oncology | 5 |
argenx SE News
- 6 days ago - argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference - MarketBeat
- 7 days ago - ARGX Reiterated by Wedbush -- Maintains Price Target at $1000 - GuruFocus
- 8 days ago - argenx SE Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 8 days ago - ArgenX Reports Phase 2 Extension Results For Efgartigimod In Treating Autoimmune Diseases - Nasdaq
- 8 days ago - Argenx (ARGX) Presents New Vyvgart Data at EULAR 2026 Congress - GuruFocus
- 8 days ago - Argenx presents new Vyvgart data at EULAR - TheFly
- 8 days ago - argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren's Disease at EULAR 2026 - GlobeNewsWire
- 10 days ago - ARGX Maintained by Wells Fargo -- Price Target Raised to $1291 - GuruFocus